TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Thu Jul 2

NL

Article

gbudwell published an article 12:43 PM

Why Applied Genetic Technologies Corporation Stock Jumped Today

Shares of Applied Genetic Technologies Corporation bolted higher today. Here's why.

Tue Jun 30

NL

Article

gbudwell published an article 11:17 AM

Why Juno Therapeutics Stock Soared Today

Juno Therapeutics saw its shares rise by 33% today. Here's why.

Mon Jun 29

NL

Article

gbudwell published an article 7:44 AM

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Sun Jun 28

NL

Article

gbudwell published an article 9:21 AM

Why Aratana Therapeutics, Inc. Stock Skyrocketed

Aratana Therapeutics' shares jumped by 24% in after-hours trading last Friday. Here's why.

Sat Jun 27

NL

Article

gbudwell published an article 10:13 PM

This Biotech Stock Has Jaw-Dropping Growth Potential

Geron Corp. is small-cap biotech with major growth potential.

Thu Jun 25

NL

Article

gbudwell published an article 10:43 PM

3 Common Pitfalls Biotech Investors Need to Learn to Avoid

Here is a look at three common mistakes investors make when buying biotech stocks.

Wed Jun 24

NL

Article

gbudwell published an article 10:41 PM

Biotech Stocks: 2 to Avoid, 1 to Buy

Arrowhead Research Corp. and Galena Biopharma are two speculative biotech stocks that investors may want to avoid, while top dog Celgene Corp. still looks like a great pick up. Here's why.

NL

Article

gbudwell published an article 10:56 AM

Why Catalyst Pharmaceuticals, Inc. Stock Jumped Today

Shares of Catalyst Pharmaceuticals bolted higher today by double-digits. Here's why.

Tue Jun 23

NL

Article

gbudwell published an article 7:53 AM

Better Dividend Stock: AbbVie or Johnson & Johnson?

AbbVie and Johnson & Johnson are widely recognized as top-tier dividend stocks. Here is a look at which one offers the better long-term prospects for income-seeking investors.

Wed Jun 17

NL

Article

gbudwell published an article 10:52 AM

Why Kythera Biopharmaceuticals, Inc. Stock Soared Today

Kythera Biopharmaceuticals stock exploded higher today. Here's why.

NL

Article

gbudwell published an article 5:09 AM

Are These Heavily Shorted Biotech Stocks Good Contrarian Buys?

Short-sellers have piled into Adaptimmune Therapeutics and MannKind Corp. this year. Could these two biotechs represent good contrarian buys for the long-term investor?

Tue Jun 16

NL

Article

gbudwell published an article 11:40 AM

Why Avalanche Biotechnologies, Inc. Stock Collapsed Today

Avalanche Biotechnologies saw its share price plummet today on exceptional volume. Here's why.

Mon Jun 15

NL

Article

gbudwell published an article 8:28 AM

What Is Cancer Immunotherapy?

Cancer immunotherapy is rapidly becoming a major new weapon in the fight against this deadly disease. Here is a brief primer on this powerful new technology, as well as a look at where it's likely headed moving forward.

Sun Jun 14

NL

Article

gbudwell published an article 9:59 PM

What Is Carl Icahn's Net Worth?

A look at the billionaire activist investor and hedge-fund manager, including some cautionary tales.

Fri Jun 12

NL

Article

gbudwell published an article 3:46 AM

Why Bristol-Myers Squibb Co.'s Stock Could Sink

Bristol-Myers Squibb's share price has been going through the roof due to the company's emergence as a leader in the field of immuno-oncology. This big pharma's high-flying days might be numbered, however. Here's why.

Wed Jun 10

NL

Article

gbudwell published an article 10:49 AM

Cholesterol Drug Blues: Why Esperion Therapeutics' Stock Is Getting Crushed Today

Shares of Esperion Therapeutics cratered today. Here's why.

NL

Article

gbudwell published an article 10:04 AM

Cancer Stocks: 2 to Sell, 1 to Buy

Advaxis, Ariad Pharmaceuticals, and Exelixis Inc. are three cancer fight companies that could generate out-sized gains for investors. A deeper look, however, suggests that only one company is a compelling buy right now.

NL

Article

gbudwell published an article 7:52 AM

Why I'm Shorting Biotech

Biotech has been crushing the broader markets for several years running at this point. However, this amazing run might be about to come to a screeching halt, making now a good time to short biotech.

Tue Jun 9

NL

Article

gbudwell published an article 1:52 AM

Cancer Stocks: 2 to Sell, 1 to Buy

Advaxis, Ariad Pharmaceuticals, and Exelixis Inc. are three cancer fight companies that could generate out-sized gains for investors. A deeper look, however, suggests that only one company is a compelling buy right now.

Mon Jun 8

NL

Article

gbudwell published an article 10:56 AM

Why MannKind Corp. Stock Bolted Higher Today

MannKind's stock has been on fire over the last few days. Here's why.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75204
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 3
Total Picks 9
Best Pick ALXN (+17.09)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts